These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 17259329)

  • 1. Latent and polymeric antithrombin: clearance and potential thrombotic risk.
    Corral J; Rivera J; Guerrero JA; Miñano A; Alberca I; Hernández-Espinosa D; Ordóñez A; Martínez C; Navarro-Núñez L; González-Conejero R; Lozano ML; Vicente V
    Exp Biol Med (Maywood); 2007 Feb; 232(2):219-26. PubMed ID: 17259329
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyperglycaemia impairs antithrombin secretion: possible contribution to the thrombotic risk of diabetes.
    Hernández-Espinosa D; Ordóñez A; Miñano A; Martínez-Martínez I; Vicente V; Corral J
    Thromb Res; 2009 Sep; 124(4):483-9. PubMed ID: 19573895
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of conformational transformation of antithrombin in blood with crossed immunoelectrophoresis: new application for a classical method.
    Corral J; Rivera J; Martínez C; González-Conejero R; Miñano A; Vicente V
    J Lab Clin Med; 2003 Nov; 142(5):298-305. PubMed ID: 14647033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The conformational basis of thrombosis.
    Carrell RW; Huntington JA; Mushunje A; Zhou A
    Thromb Haemost; 2001 Jul; 86(1):14-22. PubMed ID: 11487000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of citrullination on the function and conformation of antithrombin.
    Ordóñez A; Martínez-Martínez I; Corrales FJ; Miqueo C; Miñano A; Vicente V; Corral J
    FEBS J; 2009 Nov; 276(22):6763-72. PubMed ID: 19843180
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Commercial antithrombin concentrate contains inactive L-forms of antithrombin.
    Chang WS; Harper PL
    Thromb Haemost; 1997 Feb; 77(2):323-8. PubMed ID: 9157590
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors with conformational effects on haemostatic serpins: implications in thrombosis.
    Hernández-Espinosa D; Ordóñez A; Vicente V; Corral J
    Thromb Haemost; 2007 Sep; 98(3):557-63. PubMed ID: 17849043
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiangiogenic antithrombin.
    O'Reilly MS
    Semin Thromb Hemost; 2007 Oct; 33(7):660-6. PubMed ID: 18000792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Separation of native and latent forms of human antithrombin by hydrophobic interaction high-performance liquid chromatography.
    Karlsson G; Winge S
    Protein Expr Purif; 2001 Feb; 21(1):149-55. PubMed ID: 11162400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Formation of the antithrombin heterodimer in vivo and the onset of thrombosis.
    Zhou A; Huntington JA; Carrell RW
    Blood; 1999 Nov; 94(10):3388-96. PubMed ID: 10552948
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The reduced anticoagulant effect of fondaparinux at low antithrombin levels.
    Dempfle CE; Eichner J; Suvajac N; Ahmad-Nejad P; Neumaier M; Borggrefe M
    Anesth Analg; 2009 Sep; 109(3):712-6. PubMed ID: 19690236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antithrombin activity is inhibited by acrolein and homocysteine thiolactone: Protection by cysteine.
    Gugliucci A
    Life Sci; 2008 Feb; 82(7-8):413-8. PubMed ID: 18206177
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel anti-angiogenic form of antithrombin with retained proteinase binding ability and heparin affinity.
    Larsson H; Akerud P; Nordling K; Raub-Segall E; Claesson-Welsh L; Björk I
    J Biol Chem; 2001 Apr; 276(15):11996-2002. PubMed ID: 11278631
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in antithrombin and fibrinogen levels during induction chemotherapy with L-asparaginase in adult patients with acute lymphoblastic leukemia or lymphoblastic lymphoma. Use of supportive coagulation therapy and clinical outcome: the CAPELAL study.
    Hunault-Berger M; Chevallier P; Delain M; Bulabois CE; Bologna S; Bernard M; Lafon I; Cornillon J; Maakaroun A; Tizon A; Padrazzi B; Ifrah N; Gruel Y;
    Haematologica; 2008 Oct; 93(10):1488-94. PubMed ID: 18728028
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
    EFSA GMO Panel Working Group on Animal Feeding Trials
    Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pasteurization of antithrombin without generation of the prelatent form of antithrombin.
    Karlsson G
    Protein Expr Purif; 2004 Jun; 35(2):381-6. PubMed ID: 15135417
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of acrolein, a natural occurring aldehyde, on the anticoagulant serpin antithrombin.
    Martínez-Martínez I; Ordóñez A; Guerrero JA; Pedersen S; Miñano A; Teruel R; Velázquez L; Kristensen SR; Vicente V; Corral J
    FEBS Lett; 2009 Oct; 583(19):3165-70. PubMed ID: 19729010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Latent antithrombin and its detection, formation and turnover in the circulation.
    Mushunje A; Evans G; Brennan SO; Carrell RW; Zhou A
    J Thromb Haemost; 2004 Dec; 2(12):2170-7. PubMed ID: 15613023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo effects of hyperthermia on the functional and conformational characteristics of antithrombin.
    Hernández-Espinosa D; Mota R; Miñano A; Ordóñez A; Yélamos J; Vicente V; Corral J
    J Thromb Haemost; 2007 May; 5(5):963-70. PubMed ID: 17472584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antithrombin deficiency increases thrombin activity after prolonged cardiopulmonary bypass.
    Sniecinski R; Szlam F; Chen EP; Bader SO; Levy JH; Tanaka KA
    Anesth Analg; 2008 Mar; 106(3):713-8, table of contents. PubMed ID: 18292407
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.